Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Whitehawk Therapeutics (WHWK) over the last 4 years, with Q3 2025 value amounting to $2.4 million.

  • Whitehawk Therapeutics' Treasury Shares rose 65529.95% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 65529.95%. This contributed to the annual value of $256490.0 for FY2024, which is 68779.41% up from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Treasury Shares of $2.4 million as of Q3 2025, which was up 65529.95% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Whitehawk Therapeutics' Treasury Shares ranged from a high of $2.4 million in Q2 2025 and a low of $32558.0 during Q4 2023
  • Moreover, its 3-year median value for Treasury Shares was $325628.0 (2024), whereas its average is $779755.6.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Treasury Shares skyrocketed by 68779.41% in 2024, and later crashed by 5261.03% in 2025.
  • Whitehawk Therapeutics' Treasury Shares (Quarter) stood at $32558.0 in 2023, then skyrocketed by 687.79% to $256490.0 in 2024, then surged by 834.69% to $2.4 million in 2025.
  • Its Treasury Shares was $2.4 million in Q3 2025, compared to $2.4 million in Q2 2025 and $161721.0 in Q1 2025.